Moderator
Gunnar Esiason, RA Ventures, New Canaan, CT, United States
Speakers
Hayley Chapman, The Synergist, Oakville, ON, Canada; Joshua Makower, MD, Stanford University Schools of Medicine and Engineering; Stanford Mussallem Center for Biodesign, Stanford, CA, United States; Julia F. Slejko, PhD, University of Maryland Baltimore, Baltimore, MD, United States
Amid growing global uncertainty around pricing and reimbursement for innovative medical technologies—and mounting pressure from aging populations and rising healthcare costs—healthcare innovation faces intensifying scrutiny of value. At the same time, capital has become more selective and development risk remains high.
In this environment, patient-centered research is emerging as a critical tool for enhancing both the clinical and commercial success of pipeline products. Recent advances enable rigorous qualitative and quantitative capture of patient and caregiver perspectives across the product lifecycle—from optimizing clinical trial design to informing investment diligence and strengthening value narratives in pricing and access discussions.
This session will explore cutting-edge methodologies, examine real-world applications for innovators and investors, and outline practical cross-stakeholder actions to embed patient insights more systematically into healthcare decision-making.
Speakers to be added.
Topic
Patient-Centered Research